• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What is the "best" platinum: cisplatin, carboplatin, or oxaliplatin?

作者信息

Lokich J

机构信息

Neoplastic Disease, The Cancer Center of Boston in Boston, Framingham, and Plymouth, Massachusetts 02120, USA.

出版信息

Cancer Invest. 2001;19(7):756-60. doi: 10.1081/cnv-100106152.

DOI:10.1081/cnv-100106152
PMID:11577818
Abstract
摘要

相似文献

1
What is the "best" platinum: cisplatin, carboplatin, or oxaliplatin?哪种“最佳”铂类药物：顺铂、卡铂还是奥沙利铂？
Cancer Invest. 2001;19(7):756-60. doi: 10.1081/cnv-100106152.
2
Platinum compounds in the treatment of advanced breast cancer.铂类化合物在晚期乳腺癌治疗中的应用
Clin Breast Cancer. 2001 Oct;2(3):190-208; discussion 209. doi: 10.3816/CBC.2001.n.022.
3
[Pharmacology of platinum compounds: differences between the three molecules and factors of interpatient variability].[铂类化合物的药理学：三种分子之间的差异及患者间变异性因素]
Bull Cancer. 2011 Nov;98(11):1253-61. doi: 10.1684/bdc.2011.1464.
4
Toxicity of platinum compounds.铂化合物的毒性。
Expert Opin Pharmacother. 2003 Jun;4(6):889-901. doi: 10.1517/14656566.4.6.889.
5
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.奥沙利铂、四铂、顺铂和卡铂：在耐药细胞系及美国国立癌症研究所抗癌药物筛选小组细胞系中的活性谱。
Biochem Pharmacol. 1996 Dec 24;52(12):1855-65. doi: 10.1016/s0006-2952(97)81490-6.
6
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignancies.
Ann Oncol. 2003 Dec;14(12):1776-82. doi: 10.1093/annonc/mdg490.
7
Molecular mechanisms of resistance and toxicity associated with platinating agents.与铂类药物相关的耐药性和毒性的分子机制。
Cancer Treat Rev. 2007 Feb;33(1):9-23. doi: 10.1016/j.ctrv.2006.09.006. Epub 2006 Nov 3.
8
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.影响人大肠肿瘤细胞系对抗肿瘤铂类衍生物敏感性的因素。
Cancer Chemother Pharmacol. 2008 Sep;62(4):577-84. doi: 10.1007/s00280-007-0640-3. Epub 2007 Nov 21.
9
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.一部分含铂化疗药物通过诱导核糖体生物合成应激来杀死细胞。
Nat Med. 2017 Apr;23(4):461-471. doi: 10.1038/nm.4291. Epub 2017 Feb 27.
10
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2014 Jun 26(6):CD010885. doi: 10.1002/14651858.CD010885.pub2.

引用本文的文献

1
Targeting the NAD+/SIRT1 axis: A metabolic strategy to overcome oxaliplatin resistance in colorectal cancer.靶向NAD⁺/SIRT1轴：一种克服结直肠癌奥沙利铂耐药性的代谢策略。
World J Gastroenterol. 2025 Jun 7;31(21):106530. doi: 10.3748/wjg.v31.i21.106530.
2
Hematologic Toxicity and Bone Marrow-Sparing Strategies in Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review.局部晚期宫颈癌放化疗中的血液学毒性及骨髓保护策略：一项系统评价
Cancers (Basel). 2024 May 11;16(10):1842. doi: 10.3390/cancers16101842.
3
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes.
抗乳腺癌的金属药物：将他莫昔芬载体与铂（II）和钯（II）配合物相结合
Pharmaceutics. 2023 Feb 17;15(2):682. doi: 10.3390/pharmaceutics15020682.
4
Heterodinuclear Ru-Pt Complexes Bridged with 2,3-Bis(pyridyl)pyrazinyl Ligands: Studies on Kinetics, Deoxyribonucleic Acid/Bovine Serum Albumin Binding and Cleavage, In Vitro Cytotoxicity, and In Vivo Toxicity on Zebrafish Embryo Activities.由2,3-双（吡啶基）吡嗪基配体桥联的异双核钌-铂配合物：关于动力学、脱氧核糖核酸/牛血清白蛋白结合与切割、体外细胞毒性以及对斑马鱼胚胎活性的体内毒性的研究
ACS Omega. 2022 Jul 21;7(30):26226-26245. doi: 10.1021/acsomega.2c01845. eCollection 2022 Aug 2.
5
Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect.奥沙利铂所致神经病变：遗传和表观遗传特征，以更好地理解如何改善这种副作用。
Front Mol Biosci. 2021 May 7;8:643824. doi: 10.3389/fmolb.2021.643824. eCollection 2021.
6
Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent.接触潜在抗癌钯（II）剂后对小鼠多器官代谢的新见解
Metabolites. 2021 Feb 17;11(2):114. doi: 10.3390/metabo11020114.
7
Externally Triggered Novel Rapid-Release Sonosensitive Folate-Modified Liposomes for Gemcitabine: Development and Characteristics.外触发型新型快速释药叶酸修饰的两性霉素 B 脂质体：制备与特性。
Int J Nanomedicine. 2021 Jan 28;16:683-700. doi: 10.2147/IJN.S266676. eCollection 2021.
8
S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study.S-1 治疗晚期食管胃结合部腺癌患者的安全性：口服氟嘧啶类药物（SCOOP）研究的安全性合规观察结果。
Drugs R D. 2019 Jun;19(2):141-148. doi: 10.1007/s40268-019-0265-0.
9
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.第三个千年之交癌症药物治疗的进展
Front Pharmacol. 2018 Nov 13;9:1300. doi: 10.3389/fphar.2018.01300. eCollection 2018.
10
Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.基于尿中性粒细胞明胶酶相关脂质运载蛋白和胱抑素 C 预测接受顺铂治疗的癌症患者的急性肾损伤。
Clin Transl Sci. 2018 Jul;11(4):420-427. doi: 10.1111/cts.12547. Epub 2018 Apr 24.